webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-PEG2-bis-PEG3-BCN

  CAS No.:   Cat No.: BADC-01272   Purity: ≥95% 4.5  

Mal-PEG2-bis-PEG3-BCN is a bi-functional maleimide ADC linker combining PEG spacers and BCN for click chemistry. It enhances antibody conjugation efficiency and payload stability in ADC synthesis for targeted cancer therapy.

Mal-PEG2-bis-PEG3-BCN

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C61H95N7O20
Molecular Weight
1246.44
Shipping
-20°C (International: -20°C)
Storage
Store at -5°C,keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
-20°C (International: -20°C)
Storage
Store at -5°C,keep in dry and avoid sunlight.

Mal-PEG2-bis-PEG3-BCN, a versatile bioconjugation reagent extensively utilized in biochemical and medical research.

Protein and Antibody Conjugation: An essential tool for scientists, Mal-PEG2-bis-PEG3-BCN facilitates the modification and conjugation of proteins and antibodies. Its maleimide group selectively reacts with thiol groups in cysteine residues, enabling precise biomolecule attachment. This conjugation method is pivotal in creating antibody-drug conjugates and other biotherapeutics, enhancing their stability and efficacy in combating diseases.

Nanoparticle Functionalization: Delving into the nanoscale realm, Mal-PEG2-bis-PEG3-BCN is harnessed for nanoparticle functionalization. By enhancing solubility and biocompatibility through its PEG linker, this compound provides nanoparticles with a hydrophilic surface, minimizing non-specific interactions in biological environments.

Hydrogel Formation: The PEG chains within this reagent bestow hydrogels with customizable swelling properties and mechanical strength, essential for supporting cell encapsulation and controlled release of therapeutic agents.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-Gly-Gly-D-Phe-OtBu | t-Boc-N-amido-PEG6-propionic acid | APN-PEG4-Amine hydrochloride | Boc-amino-PEG3-SSPy | Aminooxy-PEG2-bis-PEG3-DBCO | DBCO-PEG4-SS-TCO | Mc-Leu-Gly-Arg | Hydroxy-PEG3-DBCO | Mal-C2-Gly3-EDA | Azido-PEG3-SSPy | Mal-PEG2-bis-PEG3-BCN
Send Inquiry
Verification code
Inquiry Basket